Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Natco Pharma Independent Director Dr MUR Naidu no more

Written By Ruchika Sharma1 Aug 2024 12:28 PM IST

Telangana: Natco Pharma has announced the sad demise of Dr M.U.R. Naidu, Independent Director of the Company on 30th July, 2024.Dr. M.U.R....

Zydus Lifesciences gets Mexican marketing approval for Mamitra to treat various cancers \

Written By Ruchika Sharma1 Aug 2024 11:46 AM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection...

No False Advertising Found: US Court Rejects Bayer Plea to Block Erleada Ads

Bayer submits New Drug Application to USFDA for Elinzanetant for treatment of moderate to severe vasomotor symptoms associated with menopause

Written By Ruchika Sharma1 Aug 2024 10:00 AM IST

Berlin: Bayer has announced that a New Drug Application (NDA) for the investigational compound elinzanetant has been submitted to the U.S. Food...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Duchenne muscular dystrophy: Sanofi owned biotech company sues Sarepta Therapeutics over patent infringement

Written By Ruchika Sharma31 July 2024 4:02 PM IST

Sanofi-owned biotech company Genzyme has initiated a lawsuit against competitor Sarepta Therapeutics in Delaware federal court, accusing the firm of...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Lupin bags tentative USFDA nod for HIV-1 infection drugs

Written By Ruchika Sharma31 July 2024 12:30 PM IST

Mumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug...

WHO unveils new guideline to improve global access to controlled medicines

Biological E gets WHO pre-qualification status for oral polio vaccine

Written By Ruchika Sharma31 July 2024 11:38 AM IST

Hyderabad: In a stride towards eradicating polio worldwide, Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company has...

Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human Resources

Strides Pharma Science arm incorporates company in New Zealand

Written By Ruchika Sharma29 July 2024 4:03 PM IST

Mumbai: Strides Pharma Science has announced that Strides Pharma Global Pte. Limited, Singapore, a step-down wholly owned subsidiary of the...

Granules India packaging facility in US successfully completes USFDA inspection

Indoco Remedies gets 7 USFDA observations for Goa facilities

Written By Ruchika Sharma29 July 2024 2:22 PM IST

Mumbai: Through a recent BSE filing, Indoco Remedies has informed that the Company has received seven observations in Form 483 from the...

Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial Metrics

USFDA concludes inspection at Biocon Biologics Bengaluru facilities

Written By Ruchika Sharma29 July 2024 12:53 PM IST

Bengaluru: The U.S. Food and Drug Administration (USFDA) has concluded a combined cGMP inspection and PreLicensing Inspection (PLI) at...

Dr. Reddys Labs Bags Health Canada Nod for Ozempic Generic, OneSource to Scale Supply

Dr Reddy's Labs gets positive EMA Committee opinion for proposed Rituximab biosimilar

Written By Ruchika Sharma29 July 2024 11:30 AM IST

Hyderabad: Dr Reddy's Laboratories Ltd., today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...

AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer Trial

FDA Advisory Committee reviewed Imfinzi for resectable non-small cell lung cancer based on AEGEAN Phase III trial results

Written By Ruchika Sharma28 July 2024 4:15 PM IST

The Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) has acknowledged that AstraZeneca's Imfinzi (durvalumab) met...

Pfizer Secures Vyndamax Patent Till 2031

Pfizer gets European Commission conditional marketing nod for Durveqtix for Hemophilia B

Written By Ruchika Sharma28 July 2024 12:30 PM IST

New York: Pfizer Inc. has announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok